http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3328366-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ce9d47dbf1cd1c65479e1732136a65b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-295
filingDate 2016-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc98847794f00b8cee49434172c05d5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_824105220fb2eafb4be7856e48693b28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd0100f05daf71cda1f678dc7c68573a
publicationDate 2018-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3328366-A1
titleOfInvention Aqueous formulation comprising sds, tca and a colloidal suspension of iron(ii) for use in the topical treatment of micro-organisms and parasites
abstract This invention relates to a formulation for use in the. topical treatment of diseases caused by pathogen micro- organisms and/or parasites in animals, comprising sodium dodecyl sulphate, 2, 2, 2-trichloroacetic acid and a stable colloidal suspension of (nano-) particles, of iron (III). The invention further relates to a process for the manufacture of a formulation, and uses of the same formulation and its components.
priorityDate 2015-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395361
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54685767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395360

Total number of triples: 35.